MLchartDataset catalogue

NY-ESO-1 peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015561

A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-015561
FieldOncology and biomedicine
SynonymsESO-1 Peptide Vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015561",
  "term": "NY-ESO-1 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.",
  "synonyms": [
    "ESO-1 Peptide Vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/ny-eso-1-peptide-vaccine/"
}

Record 12,037 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.